Dybly Company
Dybly develops pharmaceutical products for patients affected by the build-up of atherosclerotic plaques. Dybly has exciting next-generation compounds that are potent BET-Bromodomain inhibitors.
Industry:
Pharmaceuticals
Headquarters:
Basel, Switzerland
Founded Date:
2006
Register and Claim Ownership